Canada · Recalls · Issue #4 · 28/09 – 04/10
Canada recalls limited Sarclisa vials after possible freezing during shipment
Health Canada lists a product-quality recall concerning a limited number of Sarclisa single-use vials that may have frozen during shipment. Only some units within the identified lot are affected: a matching lot number alone does not establish that an individual vial is affected.
What the primary source says
Health Canada lists a product-quality recall concerning a limited number of Sarclisa single-use vials that may have frozen during shipment. Only some units within the identified lot are affected: a matching lot number alone does not establish that an individual vial is affected. Consult the healthcare provider about health concerns and contact the recalling firm for recall questions. Check the official notice for identification details.
Source: Health Canada, recall RA-82683. Contains information licensed under the Open Government Licence – Canada. https://open.canada.ca/en/open-government-licence-canada
Why it matters
The useful distinction
The recall is tightly limited to named units and a specific lot, so patients and healthcare providers should verify the exact product and supply chain rather than treating the whole product range as affected.
This briefing is an independent summary of the evidence sources below. Context-only links are not used as factual authority. It does not establish that a product, organisation or listing is unsafe, unlawful or non-compliant beyond what the evidence reports.